/Companies

Bridgebio

Founded 2014 · 1,034 employees on LinkedIn · 9 known investors

Find your way into Bridgebio

Sign up to see every warm intro you have to Bridgebio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Bridgebio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

BridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.

Founders & leadership

NK
Neil KumarFounder

Investors · 9

Founder mafia

5 people who came through Bridgebio went on to found or lead other companies.

Frequently asked questions

What does Bridgebio do?
BridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.
Who are Bridgebio's investors?
Bridgebio's investors include Aisling Capital, Amzak Health, EcoR1 Capital, Frazier Life Sciences, HEALTHCARE ROYALTY PARTNERS, Longwood Fund, Sequoia Capital, Viking Global and 1 more.